CD34 and hepatocellular carcinoma: The lack of difference in CD34 expression between cases with stage 2–3 fibrosis and cases with cirrhosis supports our hypothesis that many resected HCC patients with stage 2–3 fibrosis may be under-staged by routine histology alone due to fibrosis regression.